About Astrea Bioseparations
Astrea Bioseparations is a Healthcare company based in Cambridge (United Kingdom) founded in 1987, and was acquired by Biotage in February 2023. Purification and separation tools are supplied for therapeutic development. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Astrea Bioseparations has completed 1 acquisition, including Delta Precision. Its chief executive, as recorded, is Terry Pizzie. Astrea Bioseparations offers products and services including AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins. Its focus areas include Biotechnology and Bioprocessing. Its competitors include Abcam and BBI Solutions; 1 of its 2 listed competitors has raised funding.
Company details
Astrea Bioseparations is focused on delivering advanced bioseparation technologies for bioprocessing applications. The company operates within the biotechnology sector, offering solutions for cell and gene therapy, recombinant proteins, and plasma proteins. Products such as chromatography capsules, resins, and purification tools are developed to support process development and commercialization. With over 30 years of expertise, operations are geared towards meeting FDA and EMA standards. Innovation is driven by a dedicated RD team to address dynamic industry needs for speed and efficiency in delivering life-improving therapies.
- Investors
- Investments & Acquisitions
- Acquired byBiotage
(Feb 2023)
Products & Services of Astrea Bioseparations
Astrea Bioseparations offers a comprehensive portfolio of products and services, including AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins.
Capsules are provided for advanced bioprocessing purification needs.
Tools are offered for high lentiviral vector recovery.
Capsules are designed for extracellular vesicle isolation efficiency.
Solutions are provided for streamlined plasmid DNA processing.
Resins are developed for various chromatography purification methods.
Apps and channels of Astrea Bioseparations
its YouTube channel Astrea Bioseparations Ltd has 166 subscribers and 30 videos.
Videos from Astrea Bioseparations
The most watched videos on Astrea Bioseparations's YouTube channel, Astrea Bioseparations Ltd (166 subscribers). Click a video to play it here.
More on Astrea Bioseparations Ltd.
Investors in Astrea Bioseparations
Astrea Bioseparations has secured backing from 1 investor. Prominent investors backing the company include Biotage.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | 2009 | biotage.com | Uppsala, Sweden |
Investor details for Astrea Bioseparations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Astrea Bioseparations
23 people are tracked at Astrea Bioseparations (9 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Terry Pizzie | CEO | Leadership |
Dave Abbott | Head Of Engineering | Leadership |
Steve Burton | President & Chief Scientific Officer | Leadership |
Aisha Shaikh | Global Head Of Procurement | Leadership |
Justine de Ponte | Quality Assurance Partner And Auditor | Leadership |
Andrew Kellett | Chief Financial Officer & General Manager | Leadership |
Anna Tasker | Finance Director | Leadership |
Marc Hummersone | Senior Director Research & Development | Leadership |
Colin Grant | Director Of Quality And Regulatory Affairs | Leadership |
Fenglei Zhou | Research Scientist(fiber Technology) | Team |
Alistair Broom | IT Manager | Team |
Gerard Landels | Process Engineer | Team |
Zainab Shahtaj | Design Engineer | Team |
Christine Khan | Product Manager, Resins | Team |
Richard Hawkins | Quality Assurance Manager | Team |
Robert Pilkington | Quality Control Manager | Team |
Daniella Steel | Senior Product Manager | Cell And Gene Therapy | Team |
Natalie Willis | Controller; Finance Transformation | Team |
Ian Scanlon | Fiber Development Lead | Team |
Adam Pinnock | Principal Design Engineer | Team |
3 more people are available in the full profile.
Complete people profiles for Astrea Bioseparations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Astrea Bioseparations
Astrea Bioseparations has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Delta Precision.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturing and design services for chromatography products are provided. | delta-precision.co.uk | Stonehouse, United Kingdom | 2004 | Jan 2023 | •••• |
Complete acquisition details for Astrea Bioseparations
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Astrea Bioseparations
3 dated milestones of Astrea Bioseparations across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Astrea Bioseparations is founded.
- Acquisition Acquires Delta Precision.
- Exit Acquired by Biotage.
Competitors of Astrea Bioseparations
Astrea Bioseparations has 2 listed competitors in our database, 1 of them funded. They include Abcam and BBI Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | 301 | Kits and reagents are developed for life science research applications. |
Detailed competitors of Astrea Bioseparations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Astrea Bioseparations
The website of Astrea Bioseparations (astreabioseparations.com) receives about 3K visits a month.
- Monthly visits3K
▼ 11.8% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Astrea Bioseparations (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Astrea Bioseparations
Complete news archive for Astrea Bioseparations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Astrea Bioseparations
Astrea Bioseparations was founded in 1987.
Astrea Bioseparations is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Terry Pizzie is the CEO of Astrea Bioseparations, as recorded in our data.
Astrea Bioseparations is focused on delivering advanced bioseparation technologies for bioprocessing applications. The company operates within the biotechnology sector, offering solutions for cell and gene therapy, recombinant proteins, and plasma proteins. Products such as chromatography capsules, resins, and purification tools are developed to support process development and commercialization. With over 30 years of expertise, operations are geared towards meeting FDA and EMA standards. Innovation is driven by a dedicated RD team to address dynamic industry needs for speed and efficiency in delivering life-improving therapies.
Astrea Bioseparations's top competitors include Abcam and BBI Solutions.
Astrea Bioseparations offers AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins.
Astrea Bioseparations has made 1 acquisition, including Delta Precision.
Astrea Bioseparations has 1 investor. Key investors include Biotage.
Astrea Bioseparations operates through Astrea Bioseparations.
Yes. Astrea Bioseparations was acquired by Biotage in February 2023.